An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.

Trial Profile

An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2012

At a glance

  • Drugs Oxymorphone (Primary)
  • Indications Cancer pain; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Planned End Date changed from 1 Dec 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top